Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms: The MooDFOOD Randomized Clinical Trial
- PMID: 30835307
- PMCID: PMC6439597
- DOI: 10.1001/jama.2019.0556
Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms: The MooDFOOD Randomized Clinical Trial
Abstract
Importance: Effects of nutritional interventions on the prevention of major depressive disorder (MDD) in overweight adults are unknown.
Objective: To examine the effect of 2 nutritional strategies (multinutrient supplementation, food-related behavioral activation therapy) and their combination for prevention of a new MDD episode in overweight adults with subsyndromal depressive symptoms.
Design, setting, and participants: This multicenter 2 × 2 factorial randomized clinical trial included overweight adults (body mass index, 25-40) with elevated depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] scores ≥5) and no MDD episode in the past 6 months from 4 European countries. A total of 1025 adults were randomized (July 30, 2015-October 12, 2016) and followed up for 1 year (October 13, 2017).
Interventions: Daily multinutrient supplements (1412-mg omega-3 fatty acids, 30-μg selenium, 400-μg folic acid, and 20-μg vitamin D3 plus 100-mg calcium) vs placebo and 21 individual or group therapy sessions vs none (blinded to researchers) for 1 year. Participants were allocated to placebo without therapy (n = 257), placebo with therapy (n = 256), supplements without therapy (n = 256), and supplements with therapy (n = 256).
Main outcome and measures: Cumulative 1-year onset of MDD via the Mini International Neuropsychiatric Interview at 3, 6, and 12 months. Logistic regression using effect-coded variables (-1 indicating control, 1 indicating intervention) evaluated intervention effects both individually and in combination (interaction) on MDD onset.
Results: Among 1025 participants (mean age, 46.5 years; 772 women [75%]; mean BMI, 31.4), 779 (76%) completed the trial. During the 12-month follow-up, 105 (10%) developed MDD: 25 (9.7%) patients in the placebo without therapy, 26 (10.2%) in the placebo with therapy, 32 (12.5%) in the supplement without therapy, and 22 (8.6%) in the supplement with therapy group. None of the treatment strategies affected MDD onset. The odds ratio (OR) for supplements was 1.06 (95% CI, 0.87-1.29); for therapy, 0.93 (95% CI, 0.76-1.13); and for their combination, 0.93 (95% CI, 0.76-1.14; P for interaction, .48). One person in the supplementation with therapy group, died. Twenty-four patients in each of the placebo groups and 24 patients in the supplementation with therapy group were hospitalized, and 26 patients in the supplementation-only group were hospitalized.
Conclusions and relevance: Among overweight or obese adults with subsyndromal depressive symptoms, multinutrient supplementation compared with placebo and food-related behavioral activation therapy compared with no therapy did not reduce episodes of major depressive disorder during 1 year. These findings do not support the use of these interventions for prevention of major depressive disorder.
Trial registration: ClinicalTrials.gov Identifier: NCT02529423.
Conflict of interest statement
Figures


Comment in
-
Diet and Depression-From Confirmation to Implementation.JAMA. 2019 Mar 5;321(9):842-843. doi: 10.1001/jama.2019.0273. JAMA. 2019. PMID: 30835294 No abstract available.
-
Multinutrient Supplementation for Prevention of Major Depressive Disorder in Overweight Adults.JAMA. 2019 Jul 23;322(4):366. doi: 10.1001/jama.2019.6467. JAMA. 2019. PMID: 31334783 No abstract available.
Similar articles
-
Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder.Nutrients. 2022 Jul 28;14(15):3099. doi: 10.3390/nu14153099. Nutrients. 2022. PMID: 35956276 Free PMC article. Review.
-
Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial.BMC Psychiatry. 2016 Jun 8;16:192. doi: 10.1186/s12888-016-0900-z. BMC Psychiatry. 2016. PMID: 27277946 Free PMC article. Clinical Trial.
-
Acceptability and feasibility of two interventions in the MooDFOOD Trial: a food-related depression prevention randomised controlled trial in overweight adults with subsyndromal symptoms of depression.BMJ Open. 2020 Sep 15;10(9):e034025. doi: 10.1136/bmjopen-2019-034025. BMJ Open. 2020. PMID: 32933954 Free PMC article. Clinical Trial.
-
Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.JAMA. 2021 Dec 21;326(23):2385-2394. doi: 10.1001/jama.2021.21187. JAMA. 2021. PMID: 34932079 Free PMC article. Clinical Trial.
-
The Way to a Human's Brain Goes Through Their Stomach: Dietary Factors in Major Depressive Disorder.Front Neurosci. 2020 Dec 7;14:582853. doi: 10.3389/fnins.2020.582853. eCollection 2020. Front Neurosci. 2020. PMID: 33364919 Free PMC article. Review.
Cited by
-
Comorbid depression in medical diseases.Nat Rev Dis Primers. 2020 Aug 20;6(1):69. doi: 10.1038/s41572-020-0200-2. Nat Rev Dis Primers. 2020. PMID: 32820163 Review.
-
Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.JAMA. 2020 Aug 4;324(5):471-480. doi: 10.1001/jama.2020.10224. JAMA. 2020. PMID: 32749491 Free PMC article. Clinical Trial.
-
Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder.Nutrients. 2022 Jul 28;14(15):3099. doi: 10.3390/nu14153099. Nutrients. 2022. PMID: 35956276 Free PMC article. Review.
-
Relationship between critical care nutrition and post-intensive care syndrome in surviving ventilated patients with COVID-19: a multicenter prospective observational study.J Clin Biochem Nutr. 2024 Jan;74(1):74-81. doi: 10.3164/jcbn.23-66. Epub 2023 Aug 11. J Clin Biochem Nutr. 2024. PMID: 38292118 Free PMC article.
-
The metabolome-wide signature of major depressive disorder.Mol Psychiatry. 2024 Dec;29(12):3722-3733. doi: 10.1038/s41380-024-02613-6. Epub 2024 Jun 7. Mol Psychiatry. 2024. PMID: 38849517
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous